Medicines Australia Ltd.

11/19/2026 | Press release | Distributed by Public on 11/19/2026 00:20

Affordable medicines welcomed but cold comfort if shelves are empty and medicines are missing

Affordable medicines welcomed but cold comfort if shelves are empty and medicines are missing

19 November 2026: Reports that government may keep medicines listed on the Pharmaceutical Benefits Scheme at $25 is good for consumers but will not help those patients trying to access missing medicines in Australia.

The government's move masks the reality that patients in Australia are missing out on life-changing medicines with as many as 200 medicines that are available overseas not being available in Australia. Medicines Australia research shows that only 25 per cent of medicines launched globally over the past decade have been listed on the PBS in Australia - the Australian approval rate compares with 88 per cent in the United States and 46 per cent in the United Kingdom.1

Medicines Australia CEO Elizabeth de Somer said that while it was important for the government to take steps to keep the cost of medicines for patients down, it must acknowledge that fewer life changing medicines are actually making it to Australia in the first place and some medicines are actually disappearing from the Australian market.

"The reality is that they must acknowledge that Australian patients are continuing to miss out on life saving, innovative medicines because of the failure to invest more to bring these medicines to Australia," Ms de Somer said.

"The PBS needs saving and Australian patients must have innovative medicines funded, not cut.

"I think if Australians understood that their government was spending less and less on innovative medicines that are used to treat cancer, schizophrenia, prostate cancer, Crohn's disease and other rare conditions - that are available overseas - they would be rightfully disappointed."

A recent report from Insight Economics demonstrates that government spending on medicines as a share of GDP has fallen by 39 per cent since 2006, with spend per innovative medicine script down by 28 per cent in the last five years.2

According to the 2025-26 Department of Health Annual Report:

- net spending on the PBS has fallen from 13 per cent to 11 per cent of the Health Budget from FY2016 to FY2026

- and they confirm that net spend on the PBS has fallen as a share of GDP from 0.55 per cent to 0.48 per cent from FY2016 to FY2026

Medicines Australia has been advocating for major reforms to the way medicines are listed on the PBS, with a 2024 Review of the Health Technology Assessment process sitting untouched by the government, that contains 50 recommendations that would go some way to fixing this issue.

Recent research by Medicines Australia shows that patients are now waiting an average of 3.6 years for access to treatments already available overseas.3

"The government must understand that increased spending on innovative medicines is a long-term investment in the health of our nation, along with a major driver of productivity," Ms de Somer said.

"We absolutely support measures that keep the cost of medicines down, but what is the point of that when Australians can't even get access to the newest, most innovative medicines that are available overseas?"

-ENDS-

[1] https://www.medicinesaustralia.com.au/media-release/australian-patients-missing-three-quarters-of-new
medicines/

[2] www.abbvie.com.au/who-we-are/state-of-the-nation.html

[3] https://www.medicinesaustralia.com.au/media-release/new-report-waitlist-for-life-saving-medicines-extends-to
years-for-australian-consumers-and-patients/

Media enquiries:
Jonathan Hawkes, Senior Media Advisor, Medicines Australia - 0434 660 801 or [email protected]

Medicines Australia Ltd. published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 06:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]